Genital herpes - the disease and its treatment including intravenous acyclovir - PubMed
Review
Genital herpes - the disease and its treatment including intravenous acyclovir
A Mindel et al. J Antimicrob Chemother. 1983 Sep.
Abstract
This paper firstly reviews the natural history of genital herpes, giving special attention to the differences between primary and non-primary initial disease and recurrent disease and between herpes simplex virus 1 and 2. Secondly, previous therapies for genital herpes, and in particular the problems associated with previous drug trials are considered. The final part of the paper reviews a double-blind placebo controlled randomized study of intravenous acyclovir in patients with severe first attack, genital herpes. Intravenous acyclovir significantly reduced the duration of viral shedding, the healing time, the duration of vesicles and new lesion formation, and the duration of all symptoms, but did not prevent subsequent recurrences.
Similar articles
-
Peacock JE Jr, Kaplowitz LG, Sparling PF, Durack DT, Gnann JW Jr, Whitley RJ, Lovett M, Bryson YJ, Klein RJ, Friedman-Kien AE, et al. Peacock JE Jr, et al. Am J Med. 1988 Sep;85(3):301-6. doi: 10.1016/0002-9343(88)90578-5. Am J Med. 1988. PMID: 3046350 Clinical Trial.
-
Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy.
Fiddian AP, Kinghorn GR, Goldmeier D, Rees E, Rodin P, Thin RN, de Konig GA. Fiddian AP, et al. J Antimicrob Chemother. 1983 Sep;12 Suppl B:67-77. doi: 10.1093/jac/12.suppl_b.67. J Antimicrob Chemother. 1983. PMID: 6355053 Review.
-
Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir.
Corey L, Mindel A, Fife KH, Sutherland S, Benedetti J, Adler MW. Corey L, et al. Sex Transm Dis. 1985 Oct-Dec;12(4):215-8. doi: 10.1097/00007435-198510000-00009. Sex Transm Dis. 1985. PMID: 3001952 Clinical Trial.
-
Genital herpes: oral treatment with acyclovir.
Ruhnek-Forsbeck M. Ruhnek-Forsbeck M. Scand J Infect Dis Suppl. 1985;47:63-6. Scand J Infect Dis Suppl. 1985. PMID: 3912973 Clinical Trial.
-
Corey L, Benedetti J, Critchlow C, Mertz G, Douglas J, Fife K, Fahnlander A, Remington ML, Winter C, Dragavon J. Corey L, et al. J Antimicrob Chemother. 1983 Sep;12 Suppl B:79-88. doi: 10.1093/jac/12.suppl_b.79. J Antimicrob Chemother. 1983. PMID: 6355054 Review.
Cited by
-
Chemotherapy of herpesvirus infections: present successes and future hopes.
Crowe S, Mills J. Crowe S, et al. Eur J Clin Microbiol. 1985 Oct;4(5):459-63. doi: 10.1007/BF02014424. Eur J Clin Microbiol. 1985. PMID: 2998787 No abstract available.
-
Wagstaff AJ, Faulds D, Goa KL. Wagstaff AJ, et al. Drugs. 1994 Jan;47(1):153-205. doi: 10.2165/00003495-199447010-00009. Drugs. 1994. PMID: 7510619 Review.
-
O'Brien JJ, Campoli-Richards DM. O'Brien JJ, et al. Drugs. 1989 Mar;37(3):233-309. doi: 10.2165/00003495-198937030-00002. Drugs. 1989. PMID: 2653790 Review.
-
Prophylaxis for genital herpes. Should it be used routinely?
Mindel A. Mindel A. Drugs. 1991 Mar;41(3):319-25. doi: 10.2165/00003495-199141030-00001. Drugs. 1991. PMID: 1711440 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical